Bertha A. Bouroncle, M.D., F.A.C.P.; Charles A. Doan, M.D., M.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Splenectomy and corticosteroids are recognized therapeutic measures for the treatment of idiopathic thrombocytopenic purpura. In our overall evaluation of 271 patients, previously reported, 7.7% were refractory to both methods of therapy.
During the past 3½ years we have treated 16 of these cases of refractory idiopathic thrombocytopenic purpura for long-term therapy with the immunosuppressive drug azathioprine (Immuran®).
Doses of 1.2 to 4.2 mg/kg body weight (50 to 250 mg) daily, which were effective in obtaining a remission, have practically no toxic effects. Only two patients had moderate degree of leukopenia, which was rapidly reversible. The danger of producing a general
Bertha A. Bouroncle, Charles A. Doan. Treatment of Refractory Idiopathic Thromboctopenic Purpura.. Ann Intern Med. 1968;68:1164. doi: 10.7326/0003-4819-68-5-1164_2
Download citation file:
Published: Ann Intern Med. 1968;68(5):1164.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use